Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.
Gushika ico gihe, kurongorwa canke kwitwa umuvyeyi vyari nk'indoto za kure kuri Kinjal, kubera yari afise ikibazo gikomeye ca 'beta thalassemia', ingwara yo mu maraso ituma umuntu adashobora kwinjiza ...
Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...
A one-day blood donation camp for thalassemia patients was held at the Municipal Corporation office on Thursday, with the joint ...
Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good morning, and welcome to Agios’ Fourth Quarter 2024 ...
Zacks.com on MSN3d
CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?CRISPR Therapeutics CRSP stock rose more than 25% in the past week, thanks to the encouraging fourth-quarter 2024 results and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback